Exicure (NASDAQ:XCUR) Stock Price Down 1.6% – Should You Sell?

Exicure, Inc. (NASDAQ:XCUR)’s stock price traded down 1.6% during trading on Thursday . The company traded as low as $8.40 and last traded at $8.44. 4,577 shares changed hands during mid-day trading, a decline of 95% from the average session volume of 87,654 shares. The stock had previously closed at $8.58.

Exicure Stock Up 1.3 %

The company has a market cap of $22.32 million, a P/E ratio of -4.13 and a beta of 3.76. The business’s 50 day moving average is $12.14 and its 200 day moving average is $8.07.

Hedge Funds Weigh In On Exicure

An institutional investor recently bought a new position in Exicure stock. Geode Capital Management LLC acquired a new position in Exicure, Inc. (NASDAQ:XCUR) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 12,645 shares of the company’s stock, valued at approximately $173,000. Geode Capital Management LLC owned approximately 0.48% of Exicure as of its most recent SEC filing. 42.82% of the stock is owned by institutional investors.

Exicure Company Profile

Exicure, Inc, an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology.